From: The burden of disease in Spain: results from the global burden of disease study 2010
YLDs (hundreds) | DALYs (hundreds) | |||||
---|---|---|---|---|---|---|
 | 1990 | 2010 | % Δ | 1990 | 2010 | % Δ |
All causes | 44,316.8 | 55,706.6 | 25.7% | 104,615.9 | 110,269.4 | 5.4% |
Communicable, maternal, neonatal, and nutritional disorders | 1,914.7 (1,415.3–2,628.9) | 1,942.5 (1,377.8–2,767.8) | 1% | 6,394.8 (5,773.6–7,126) | 5,067.4 (4,450.8–5,848.2) | −21% |
HIV/AIDS and tuberculosis | 285.4 (202.5–384.5) | 183 (128.5–248.3) | −36% | 1,532.1 (1,356.2–1,720.5) | 738.3 (643.6–844.3) | −52% |
  Tuberculosis | 114.8 (71.7–171.8) | 84.4 (50.8–129.2) | −26% | 340.6 (274–409.3) | 175.9 (136.8–230.7) | −48% |
  HIV/AIDS | 170.6 (123.2–223.1) | 98.6 (70.8–131.4) | −42% | 1,191.6 (1,042–1,360.4) | 562.4 (478.8–651.9) | −53% |
  HIV disease resulting in mycobacterial infection | 12.1 (6.7–19.4) | 4.7 (2–8.3) | −62% | 59.8 (51.5–69.1) | 19.6 (16–24.1) | −67% |
  HIV disease resulting in other specified or unspecified diseases | 158.4 (114.2–206.7) | 93.9 (67.9–125.4) | −41% | 1,131.7 (993.6–1,271.3) | 542.8 (469.8–629.4) | −52% |
Diarrhea, lower respiratory infections, meningitis, and other common infectious diseases | 858.5 (590.7–1249) | 925.1 (621.7–1339.5) | 8% | 2,555.5 (2,206.4–3,004.8) | 2,358.1 (1,992.4–2,814.4) | −8% |
  Diarrheal diseases | 306.2 (201.3–440.4) | 363.2 (238.6–520.2) | 19% | 358.6 (252.5–493.1) | 428.9 (305.6–585.7) | 20% |
  Typhoid and paratyphoid fevers | 0 (0–0.1) | 0 (0–0.1) | 27% | 1.1 (0.1–2) | 1 (0.1–2) | −4% |
  Lower respiratory infections | 44.3 (29.7–62) | 48.4 (33–66.8) | 9% | 1391.6 (1227.5–1612.5) | 1,275.9 (1,096–1,523.9) | −8% |
  Upper respiratory infections | 219.3 (106.2–390.9) | 227.8 (110.9–429.7) | 4% | 221 (107.8–392.7) | 228.4 (111.5–430.3) | 3% |
  Otitis media | 211.6 (127.1–339.9) | 211.9 (120.7–361) | 0.2% | 213.6 (127.9–341.7) | 213.3 (123–363.3) | 0% |
  Meningitis | 52.1 (33.7–77.9) | 46.8 (29–71.8) | −10% | 261.9 (229.8–309) | 153.7 (129.1–183.3) | −41% |
  Pneumococcal meningitis | 10.2 (6.2–15.4) | 6.7 (3.8–10.6) | −34% | 39.8 (33.2–47.3) | 21.8 (17.6–26.7) | −45% |
  H influenza type B meningitis | 7.4 (4.3–11.8) | 3.1 (1.6–5.1) | −58% | 33.7 (27.2–42.1) | 13.6 (10.8–17.3) | −60% |
  Meningococcal infection | 16.6 (10.2–25.7) | 14.6 (8.4–23.2) | −12% | 88.8 (75.5–106.7) | 50.1 (40.9–61.3) | −44% |
  Other meningitis | 17.2 (10.9–26.6) | 21.8 (13.3–33.6) | 27% | 99 (86–116.3) | 67.7 (55.6–82.7) | −32% |
  Encephalitis | 5.6 (3.3–8.7) | 5.5 (3.2–9) | −1% | 28.5 (24.7–32.7) | 17.9 (14.7–21.8) | −37% |
  Diphtheria | 0 (0–0) | 0 (0–0) | −82% | 0.9 (0–7.3) | 0.3 (0–2.5) | −66% |
  Whooping cough | 2.4 (1.3–3.8) | 0.6 (0.3–1.1) | −74% | 47.8 (2.3–221.4) | 9.3 (0.6–40.9) | −81% |
  Tetanus | 0 (0–0) | 0 (0–0) | −69% | 3.4 (0.4–13) | 0.7 (0.1–2.6) | −80% |
  Measles | 0.8 (0.3–1.4) | 0 (0–0.1) | −99% | 4 (2.2–6.4) | 1.5 (0.7–3.9) | −62% |
  Varicella | 16.2 (8.2–29.1) | 20.8 (10.1–39.2) | 29% | 23.3 (9.2–63.2) | 27.3 (11.6–67.5) | 18% |
Neglected tropical diseases and malaria | 8.5 (2.3–21.8) | 15.6 (2.5–51.2) | 83% | 69.6 (39.7–120.3) | 64.9 (35.1–120.1) | −7% |
  Malaria | 0.5 (0–3.9) | 0.1 (0–0.8) | −75% | 0.5 (0–3.9) | 0.1 (0–0.8) | −75% |
  Leishmaniasis | 1.3 (0.6–2.7) | 1.4 (0.6–2.9) | 6% | 10.6 (7.4–14.7) | 8.4 (5.8–11.5) | −21% |
  *Cysticercosis | 0 (0–0) | –* | –* | 0.6 (0–2.2) | –* | –* |
  Echinococcosis | 5.3 (0.8–18.1) | 7 (1–25.6) | 32% | 15.6 (2.2–47.7) | 12.1 (2.1–35.5) | −22% |
  Dengue | 0 (0–0) | 0 (0–0) | –* | 31.8 (9.6–70.5) | 30.9 (12.5–68.8) | −3% |
  Rabies | 0 (0–0) | 0 (0–0) | 13% | 5.6 (2.7–12.4) | 2 (1.1–3.9) | −64% |
  Food-borne trematodiases | 0.1 (0–0.4) | 0.1 (0–0.3) | −31% | 0.1 (0–0.4) | 0.1 (0–0.3) | −31% |
  Other neglected tropical diseases | 1.3 (0.1–1.6) | 7 (0.2–6.2) | 425% | 4.8 (2.5–7) | 11.3 (3–11.7) | 133% |
Maternal disorders | 14.1 (8.9–21.7) | 12.5 (7.5–19.6) | −11% | 37 (29–47.5) | 28.7 (21.7–37.2) | −22% |
  Maternal hemorrhage | 5.9 (3.4–9.5) | 5.3 (3–8.5) | −11% | 10.3 (7.4–14) | 8.5 (6–11.9) | −17% |
  Maternal sepsis | 0.3 (0–1) | 0.3 (0–1) | −9% | 1.3 (0.8–2.1) | 0.9 (0.5–1.6) | −33% |
  Hypertensive disorders of pregnancy | 0.6 (0.3–1.1) | 0.7 (0.3–1.2) | 9% | 3.9 (3–5.1) | 2.9 (2.1–3.8) | −26% |
  Obstructed labor | 1.1 (0–3.4) | 1.1 (0–3.4) | −2% | 2 (0.9–4.3) | 1.8 (0.7–4.2) | −12% |
  Abortion | 2 (1.1–3.4) | 1.4 (0.7–2.5) | −29% | 5.2 (3.9–6.8) | 3.4 (2.4–4.6) | −35% |
  Other maternal disorders | 4.1 (2.6–6.2) | 3.8 (2.3–5.8) | −8% | 14.2 (11.1–18.1) | 11.3 (8.4–14.4) | −21% |
Neonatal disorders | 224.6 (164.9–300.8) | 218.4 (162.3–282.8) | −3% | 1,468.3 (1,242.3–1,668.6) | 1,061.2 (934.7–1,183) | −28% |
  Preterm birth complications | 96.4 (66.9–136.9) | 109.4 (75.9–149.6) | 13% | 788.4 (627.9–938.5) | 533 (433–665.9) | −32% |
  Neonatal encephalopathy (birth asphyxia and birth trauma) | 126.6 (89.5–172.7) | 107 (77.3–143.6) | −15% | 425.4 (336.5–527.3) | 297.5 (235.6–375) | −30% |
  Sepsis and other infectious disorders of the newborn baby | 0.1 (0.1–0.3) | 0.3 (0.2–0.6) | 140% | 110.1 (60.9–192.3) | 111.2 (60–197.5) | 1% |
  Other neonatal disorders | 1.4 (1–2) | 1.7 (1.2–2.3) | 16% | 144.3 (91.2–262.3) | 119.5 (67.1–179.2) | −17% |
Nutritional deficiencies | 444.6 (269.2–712.5) | 507.8 (314.2–801.1) | 14% | 524.2 (347–797.2) | 590.7 (394.4–885) | 13% |
  Protein-energy malnutrition | 14.3 (9.3–21.2) | 22.7 (14.8–31.8) | 59% | 46.2 (38.5–57.6) | 75 (52.4–93.8) | 62% |
  Iodine deficiency | 427.1 (251.8–694) | 480.5 (285–763.7) | 13% | 428.8 (253.7–695.7) | 482.4 (286.9–765.8) | 13% |
  Iron-deficiency anemia | 1.1 (0.5–2) | 3 (1–3.2) | 171% | 41.8 (35.4–54.5) | 27.9 (16.9–33.7) | −33% |
  Other nutritional deficiencies | 2.2 (1.8–2.8) | 1.5 (0.9–2) | −29% | 7.5 (6.3–9.8) | 5.3 (3.2–6.9) | −29% |
Other communicable, maternal, neonatal, and nutritional disorders | 79 (38.7–149.3) | 80.1 (35.6–168.3) | 1% | 208 (161.6–281.2) | 225.5 (162.4–323.7) | 8% |
  Sexually transmitted diseases excluding HIV | 64.3 (29.6–128.4) | 56.9 (26–114) | −11% | 91.6 (56.3–157.8) | 66.6 (35.2–123.7) | −27% |
  Syphilis | 3.9 (0.2–8.7) | 4.8 (0.3–10.7) | 21% | 25.4 (15.7–39.3) | 10.9 (5–18) | −57% |
  Sexually transmitted chlamydial diseases | 25.3 (8.7–60) | 22.4 (7.6–53.6) | −12% | 26.7 (10.1–61.5) | 23.2 (8.3–54.3) | −13% |
  Gonococcal infection | 13.7 (5.2–30.2) | 14.5 (5–32.7) | 6% | 14.8 (6.1–31.3) | 15.1 (5.6–33.5) | 2% |
  Trichomoniasis | 13.3 (0.1–41.8) | 9.2 (0.1–29.1) | −31% | 13.3 (0.1–41.8) | 9.2 (0.1–29.1) | −31% |
  Other sexually transmitted diseases | 8 (2.9–18.1) | 6 (2.5–12) | −25% | 11.5 (6.2–21.5) | 8.2 (4.5–14.2) | −29% |
  Hepatitis | 12.2 (6–21.9) | 12.9 (6.2–22.8) | 6% | 67.3 (57.9–79) | 66 (55.8–77.8) | −2% |
  Acute hepatitis A | 8.3 (3.9–14.7) | 7.5 (3.7–13) | −9% | 17 (11.2–24.8) | 11 (6.5–17.6) | −35% |
  Acute hepatitis B | 2.8 (0.2–9.2) | 3.4 (0.2–10.6) | 21% | 42.8 (26.3–55.3) | 24 (12.6–43.4) | −44% |
  Acute hepatitis C | 1 (0.2–2.1) | 2 (0.4–4.1) | 87% | 7.6 (2.8–15.8) | 31 (10.5–53.4) | 308% |
  Leprosy | 0.1 (0–0.1) | 0 (0–0) | −87% | 0.1 (0–0.1) | 0 (0–0) | −87% |
  Other infectious diseases | 2.5 (0–0.3) | 10.3 (0–0.4) | 314% | 49 (37.6–81.3) | 92.8 (39.3–114.7) | 89% |
Non-communicable diseases | 38,528.9 (32,278.2–45,503.6) | 48,269.1 (40,257.6–56,616.6) | 25% | 86,260 (79,823.1–93,301.2) | 95,239.4 (87,522.2–10,3475.6) | 10% |
Neoplasms | 474.2 (349.1–630.6) | 816.4 (597.6–1074.5) | 72% | 16,917.3 (16,102.7–17,858.3) | 19,304.5 (18,003–20,302.6) | 14% |
  Esophageal cancer | 3.2 (1.6–5.3) | 3.6 (1.8–6.2) | 10% | 413.9 (310.3–535.2) | 392.1 (290.6–538.8) | −5% |
  Stomach cancer | 24.3 (15.3–35.6) | 21.2 (12.9–33) | −13% | 1,443.2 (1,131–1,931.8) | 1,007.9 (765–1,402.6) | −30% |
  Liver cancer | 6.5 (3.9–9.8) | 9.6 (5.8–14.8) | 47% | 720 (581.5–818.5) | 846.8 (712.5–1,044.6) | 18% |
  Liver cancer secondary to hepatitis B | 0.9 (0.3–1.8) | 1.3 (0.4–2.4) | 38% | 100.9 (80.1–116.3) | 119.2 (97.8–152.4) | 18% |
  Liver cancer secondary to hepatitis C | 2.8 (1.5–4.7) | 3.9 (2–6.6) | 40% | 287.9 (236.3–332.2) | 331.9 (277.3–427.1) | 15% |
  Liver cancer secondary to alcohol use | 2.2 (1.1–3.7) | 3.6 (1.9–5.9) | 64% | 253 (201.7–291.3) | 301 (253–381) | 19% |
  Other liver cancer | 0.6 (0.1–1.4) | 0.8 (0.1–1.6) | 26% | 78.2 (62.9–90.4) | 94.7 (74.6–116.3) | 21% |
  Larynx cancer | 14 (7.3–24.9) | 12.3 (6.5–23.3) | −12% | 498.7 (252.2–859.6) | 373.9 (202.3–685.2) | −25% |
  Trachea, bronchus, and lung cancers | 34.1 (22.3–49.5) | 45.5 (25.9–64.2) | 34% | 3,138.8 (2,541.8–3,982.3) | 3,686.7 (2,408.1–4,161.1) | 17% |
  Breast cancer | 122.7 (80.8–187.9) | 188.1 (120.8–277.2) | 53% | 1,496.8 (1,400.8–1,611.5) | 1,469.4 (1,340.6–1,619.2) | −2% |
  Cervical cancer | 5.4 (2.9–8.7) | 5.2 (2.7–8.6) | −4% | 226.8 (143.3–321.6) | 212.3 (135.6–306.1) | −6% |
  Uterine cancer | 10.9 (5.7–20.1) | 13.6 (5.7–23.1) | 24% | 174.1 (100.8–316.1) | 194.6 (93.5–271.9) | 12% |
  Prostate cancer | 40.2 (27–60) | 120.3 (78.9–185.9) | 199% | 609 (373.5–941.4) | 939.3 (572.7–1,489.8) | 54% |
  Colon and rectum cancers | 63.1 (44.8–85.4) | 128.7 (90.3–171.7) | 104% | 1,675.7 (1,476.6–1,895.5) | 2,452.4 (2,019.5–2,711) | 46% |
  Mouth cancer | 12.4 (8.2–17.8) | 13.8 (8.9–20.3) | 12% | 307.3 (257.8–337.4) | 296.6 (250.1–367.2) | −3% |
  Nasopharynx cancer | 0.9 (0.3–1.9) | 1 (0.3–2) | 5% | 70.2 (40.1–94.4) | 63.2 (40.4–88.2) | −10% |
  Cancer of other part of pharynx and oropharynx | 4.1 (2–7) | 5.8 (2.8–9.4) | 42% | 172.5 (100.3–251.3) | 211.9 (125.8–299.5) | 23% |
  Gallbladder and biliary tract cancer | 3.6 (1.9–6.1) | 5.1 (2.5–9) | 41% | 253.9 (169.6–370.5) | 274.3 (193–414.1) | 8% |
  Pancreatic cancer | 3.9 (2–6.5) | 6.3 (3.4–10.4) | 63% | 627.8 (480.8–812.9) | 881.8 (646.5–1120.7) | 40% |
  Malignant melanoma of skin | 4.2 (2.3–7.9) | 8.6 (4.7–13.7) | 103% | 140.1 (94.4–223.2) | 207.1 (133–294.9) | 48% |
  Non-melanoma skin cancer | 15.6 (10.7–21.9) | 38 (25.9–52.8) | 143% | 89.4 (55.1–125.3) | 110.9 (80.5–165.1) | 24% |
  Ovarian cancer | 6.2 (3.6–9.8) | 9.4 (5.2–14.5) | 52% | 336.7 (252.6–453.1) | 425.2 (287.4–561.8) | 26% |
  Testicular cancer | 0.8 (0.2–1.6) | 1.4 (0.5–2.9) | 86% | 22.9 (13.7–34.8) | 22.7 (12.9–32.9) | −1% |
  Kidney and other urinary organ cancers | 5.6 (3.1–8.6) | 17.7 (10.2–30.6) | 218% | 255.5 (178.9–327.2) | 592.6 (435.2–958.7) | 132% |
  Bladder cancer | 31.7 (21.7–43.9) | 49.8 (32.2–69.6) | 57% | 617 (491.5–789.2) | 704.1 (508.2–824.7) | 14% |
  Brain and nervous system cancers | 11.5 (6.6–17.9) | 17.4 (8.7–27.2) | 51% | 716.6 (488.1–1,011.1) | 848.3 (492.4–1,050.7) | 18% |
  Thyroid cancer | 2.5 (1.3–4.4) | 4.1 (2.2–6.8) | 63% | 51.9 (40.5–66.8) | 61.5 (45.7–78.9) | 18% |
  Hodgkin’s disease | 2.4 (1–4.2) | 2.1 (0.9–3.9) | −11% | 112.8 (73.1–166.8) | 72.3 (47.9–109.7) | −36% |
  Non-Hodgkin’s lymphoma | 9.4 (6–13.8) | 16.1 (10–23.9) | 72% | 417.3 (366.4–493.7) | 503.5 (364.3–578.3) | 21% |
  Multiple myeloma | 5.4 (2.8–9) | 8.3 (4.3–13.5) | 55% | 212.7 (146.8–305.2) | 275.6 (182.9–388.8) | 30% |
  Leukemia | 10.4 (6.7–15.4) | 16.1 (10–23.5) | 55% | 705.9 (575.5–880) | 688.4 (544.1–817) | −2% |
  Other neoplasms | 19.2 (12.4–28.5) | 47.2 (30–69.8) | 145% | 1,409.8 (1,108.1–1,845.1) | 1,489.3 (1,190.5–2,016.9) | 6% |
Cardiovascular and circulatory diseases | 1,911.6 (1,475.9–2,423) | 2,864.9 (2,268.9–3,499.4) | 50% | 20,076.7 (18,998.5–20,904.2) | 17,802 (16,834.2–19,181.8) | −11% |
  Rheumatic heart disease | 125.4 (77.4–198.2) | 139.1 (93.2–207.5) | 11% | 823.4 (745.2–933.8) | 507.3 (429.5–599) | −38% |
  Ischemic heart disease | 737.6 (477.9–1108) | 974.8 (636–1420.7) | 32% | 9,202.7 (8,705.1–9,952.4) | 8,055.8 (7,462.7–8,876.3) | −12% |
  Cerebrovascular disease | 337.1 (278.1–393.5) | 640.5 (529.3–755.2) | 90% | 6,437.3 (5,648.1–6,783.7) | 4,752.8 (4,252.9–5,829.1) | −26% |
  Ischemic stroke | 271.4 (225–318.7) | 515.9 (426.9–609.4) | 90% | 4,130.9 (3,546.5–4,389.3) | 3,011 (2,635.2–4,183.6) | −27% |
  Hemorrhagic and other non-ischemic stroke | 65.6 (54.3–77.7) | 124.6 (102.1–147.8) | 90% | 2,306.5 (2,058.8–2,601.6) | 1,741.8 (1,502.3–1,936) | −24% |
  Hypertensive heart disease | 28.3 (17.3–42.8) | 46.5 (28.8–71.4) | 65% | 531.9 (432.3–671.4) | 613 (490.4–764.1) | 15% |
  Cardiomyopathy and myocarditis | 17.5 (10.3–27.4) | 26.6 (16.3–40.9) | 52% | 537.7 (496.6–569.2) | 723.9 (634–857.1) | 35% |
  Atrial fibrillation and flutter | 278.3 (186.1–398) | 460.9 (306.5–658) | 66% | 363.2 (269.6–484.1) | 849.2 (631.8–1127.7) | 134% |
  Aortic aneurysm | 0 (0–0) | 0 (0–0) | –* | 261.2 (199.7–339.1) | 308.2 (224.6–403.1) | 18% |
  Peripheral vascular disease | 39.5 (20.1–70.8) | 60.7 (30.8–109.7) | 54% | 83.5 (54.6–124.9) | 174.6 (116.3–253.8) | 109% |
  Endocarditis | 4.2 (2.4–6.8) | 7.4 (4.5–11.6) | 75% | 74.6 (64–86.9) | 76.3 (59.9–88) | 2% |
  Other cardiovascular and circulatory diseases | 343.8 (182.1–561.1) | 508.7 (275.7–807.5) | 48% | 1,761.1 (1,592.8–1,992.2) | 1,740.9 (1,496.8–2,046.5) | −1% |
Chronic respiratory diseases | 1,935.1 (1,247–2,764.6) | 22,17.7 (14,39.4–31,23.6) | 15% | 5,623.2 (4,907.3–6,436.1) | 5,260.3 (4,434.9–6,184.9) | −6% |
  Chronic obstructive pulmonary disease | 860.7 (5,23.1–1,276.8) | 10,99.1 (683–15,94.7) | 28% | 3,030.1 (2,586.4–3,515.9) | 2,916 (2,423.7–3,483.1) | −4% |
  Pneumoconiosis | 8.3 (5.3–12) | 15.9 (10–23.7) | 92% | 195.7 (134.5–283) | 158.8 (112.5–223.2) | −19% |
  Asthma | 749.4 (411.4–1,203.2) | 791.4 (443–1,253.1) | 6% | 969.4 (632.4–1423.6) | 917.8 (564.5–1377.3) | −5% |
  Interstitial lung disease and pulmonary sarcoidosis | 8.9 (5.9–13.3) | 16.1 (10.4–24.3) | 81% | 158.8 (118.1–251.5) | 262.6 (181.8–373) | 65% |
  Other chronic respiratory diseases | 307.9 (187–458.9) | 295.2 (183.7–431.1) | −4% | 1,269.2 (988–1,483.8) | 1,005.2 (819.7–1,264) | −21% |
Cirrhosis of the liver | 34.4 (21.9–49.6) | 37.6 (24.3–54) | 9% | 2,358.1 (1,931.4–2,609.8) | 1,772.7 (1585.9–2,231.2) | −25% |
  Cirrhosis of the liver secondary to hepatitis B | 1.3 (0.5–2.5) | 1.3 (0.5–2.6) | 4% | 89.4 (70.2–105.5) | 67.9 (57–86.1) | −24% |
  Cirrhosis of the liver secondary to hepatitis C | 13.2 (7.4–21.5) | 14.4 (7.7–23.3) | 9% | 895 (711.6–1049.2) | 687.1 (582–870.4) | −23% |
  Cirrhosis of the liver secondary to alcohol use | 15.8 (8.9–25) | 17.5 (9.9–28.4) | 11% | 1,105.7 (847.2–1295.5) | 830.5 (694.9–1,084.7) | −25% |
  Other cirrhosis of the liver | 4.1 (2–6.9) | 4.3 (2.1–7.6) | 4% | 268 (211.1–313.4) | 187.2 (156.9–238.2) | −30% |
Digestive diseases (except cirrhosis) | 423.2 (248.1–730.7) | 492.4 (313.7–755.8) | 16% | 1,683 (1,452.6–2,012.8) | 1,860 (1,610.1–2,164.5) | 11% |
  Peptic ulcer disease | 34 (17.9–64.8) | 21.8 (11–46.2) | −36% | 251.8 (202.3–293.9) | 116.2 (95–164.7) | −54% |
  Gastritis and duodenitis | 29.9 (19.3–44.6) | 38.8 (25.8–56.3) | 30% | 46.9 (33.4–62.6) | 46.5 (32.1–65) | −1% |
  Appendicitis | 7.8 (2.8–16.7) | 8.3 (3–17.8) | 6% | 43.7 (30.9–65.7) | 37.7 (22.8–52.5) | −14%   |
  Paralytic ileus and intestinal obstruction without hernia | 0.6 (0–2.7) | 0.6 (0–2.6) | 3% | 123.3 (96.4–175.4) | 169.4 (106.6–226.9) | 37% |
  Inguinal or femoral hernia | 28.3 (6.6–84) | 28.9 (5.7–81.8) | 2% | 55.8 (33.9–110.3) | 48.7 (25.4–101.4) | −13% |
  Non-infective inflammatory bowel disease | 205.8 (88.9–434.4) | 214.3 (109.5–390.4) | 4% | 243.3 (127.2–473.9) | 257 (151.9–435.7) | 6% |
  Vascular disorders of intestine | 1 (0.2–2.4) | 1.6 (0.3–3.9) | 70% | 232.9 (117.1–468.5) | 313.5 (166–604) | 35% |
  Gall bladder and bile duct disease | 36.4 (24.5–51.6) | 45.6 (30.7–64.3) | 25% | 189.2 (161.3–229.6) | 207.8 (164.8–260.5) | 10% |
  Pancreatitis | 16.3 (5.8–38.3) | 37.2 (12.8–83.9) | 128% | 224.4 (164.8–275.8) | 228.1 (177–303.9) | 2% |
  Other digestive diseases | 63.2 (37–108.4) | 95.3 (60.6–146.9) | 51% | 271.7 (228–356.4) | 435.1 (337.6–529.1) | 60% |
Neurological disorders | 3,407 (2,631.9–4,321.9) | 4,627.9 (3,616.3–5,804.5) | 36% | 4,581 (3,789.1–5,481.9) | 7,372.4 (6,127.5–8,666.4) | 61% |
  Alzheimer's disease and other dementias | 858.3 (612.7–1,136) | 1,640.7 (1,185–2,196.8) | 91% | 1,433.9 (1,138.4–1,754.3) | 3,518 (,2707.8–4,334.5) | 145% |
  Parkinson's disease | 71.8 (46–114.3) | 115.7 (72.9–189) | 61% | 230.4 (180.8–300.8) | 390 (290.8–496.1) | 69% |
  Epilepsy | 292 (215.3–381.1) | 324 (242.9–425.2) | 11% | 399.4 (320.1–491.9) | 432.1 (343–538.1) | 8% |
  Multiple sclerosis | 37.7 (26.5–51) | 54.5 (37.3–74.1) | 45% | 82.1 (67.6–98.9) | 109 (86.3–133.8) | 33% |
  Migraine | 1,893.5 (1,198.1–2,731.1) | 2,146 (1,339.7–3,101.9) | 13% | 1893.5 (1198.1–2731.1) | 2146 (1339.7–3101.9) | 13% |
  Tension-type headache | 117.1 (65.8–188) | 144.1 (82.7–233.9) | 23% | 117.1 (65.8–188) | 144.1 (82.7–233.9) | 23% |
  Other neurological disorders | 136.7 (102.7–176.2) | 202.8 (153.7–261.7) | 48% | 424.5 (336.1–567.1) | 633.1 (480.2–802.4) | 49% |
Mental and behavioral disorders | 10,177.2 (8,247.3–12,325.7) | 12,464.1 (10,170.8–15,032.3) | 22% | 10,528.7 (8,600.5–12,716.4) | 12,917.2 (10,630.6–15,432.4) | 23% |
  Schizophrenia | 771.1 (443.1–1,144.3) | 1,052.2 (583.9–1,591.4) | 36% | 781.6 (453.6–1,153.9) | 1,074.7 (606.8–1,614.1) | 37% |
  Alcohol use disorders | 691 (381.2–1156.4) | 757.1 (401.2–1,235.8) | 10% | 797 (482.4–1,257.7) | 882.1 (514.8–1,385.4) | 11% |
  Drug use disorders | 1,644.7 (1,176.5–2,156.1) | 1,784.5 (1,277.6–2,334.5) | 9% | 1,873.5 (1,391–2,416.5) | 2,076 (1,536.1–2,677.5) | 11% |
  Opioid use disorders | 746.5 (502.9–1003.1) | 844.4 (571.9–1,134.8) | 13% | 886.9 (629.1–1,165.1) | 1,016.2 (728.8–1,339.5) | 15% |
  Cocaine use disorders | 195.6 (112.9–306.5) | 216.7 (124.3–335) | 11% | 199.3 (117.2–313.6) | 218.6 (124.8–338.9) | 10% |
  Amphetamine use disorders | 155.2 (86.9–249.2) | 162.1 (91.4–255.5) | 4% | 157.2 (88.8–251.8) | 164.5 (92.3–262.9) | 5% |
  Cannabis use disorders | 213.6 (107.1–377.3) | 201.5 (100.3–367.1) | −6% | 213.6 (107.1–377.3) | 201.5 (100.3–367.1) | −6% |
  Other drug use disorders | 333.8 (205.6–499.4) | 359.8 (226.7–523.5) | 8% | 416.4 (280.9–592.2) | 475.1 (327–669.2) | 14% |
  Unipolar depressive disorders | 4,011.1 (2,829.7–5,395.6) | 5,308.1 (3,910.9–7,025.8) | 32% | 4,011.1 (2,829.7–5,395.6) | 5,308.1 (3,910.9–7,025.8) | 32% |
  Major depressive disorder | 3,352.4 (2,332.1–4,626.6) | 4,521.8 (3,227.7–6,093.6) | 35% | 3,352.4 (2,332.1–4,626.6) | 4,521.8 (3,227.7–6,093.6) | 35% |
  Dysthymia | 658.7 (426.3–922.7) | 786.3 (508.1–1,094.9) | 19% | 658.7 (426.3–922.7) | 786.3 (508.1–1,094.9) | 19% |
  Bipolar affective disorder | 696.1 (425.1–1051) | 835.3 (510.6–1,251.2) | 20% | 696.1 (425.1–1051) | 835.3 (510.6–1251.2) | 20% |
  Anxiety disorders | 1,213.6 (826.9–1,673.9) | 1331.1 (906.8–1,856.4) | 10% | 1,213.6 (826.9–1,673.9) | 1,331.1 (906.8–1,856.4) | 10% |
  Eating disorders | 296.4 (171.5–476.8) | 570.1 (334.2–924.9) | 92% | 298.7 (174.6–479.3) | 574.6 (339.7–929.5) | 92% |
  Pervasive development disorders | 399.8 (269.4–578.2) | 452.2 (302.8–648.9) | 13% | 399.8 (269.4–578.2) | 452.2 (302.8–648.9) | 13% |
  Autism | 188.8 (122.7–275.7) | 216.3 (140.4–317.6) | 15% | 188.8 (122.7–275.7) | 216.3 (140.4–317.6) | 15% |
  Asperger’s syndrome | 211.1 (134.8–319.5) | 235.8 (154.4–352.7) | 12% | 211.1 (134.8–319.5) | 235.8 (154.4–352.7) | 12% |
  Childhood behavioral disorders | 291.8 (171.3–450.9) | 209.7 (120.2–323.4) | −28% | 291.8 (171.3–450.9) | 209.7 (120.2–323.4) | −28% |
  Attention-deficit hyperactivity disorder | 27 (15.2–43.6) | 20.8 (11.8–33.8) | −23% | 27 (15.2–43.6) | 20.8 (11.8–33.8) | −23% |
  Conduct disorder | 264.7 (151–419.6) | 188.9 (105–299.2) | −29% | 264.7 (151–419.6) | 188.9 (105–299.2) | −29% |
  Idiopathic intellectual disability | 92 (53.5–142.5) | 74.1 (38–123.4) | −19% | 92 (53.5–142.5) | 74.1 (38–123.4) | −19% |
  Other mental and behavioral disorders | 69.5 (41–108.2) | 89.7 (52–143.5) | 29% | 73.4 (44.8–112.2) | 99.2 (60.1–152.2) | 35% |
Diabetes, urogenital, blood, and endocrine diseases | 4,245.7 (3,050.2–5,693.7) | 5,381.9 (3,956.8–7,145.9) | 27% | 7,013.4 (5,814.5–8,532.3) | 8,414.8 (6,968.8–1,0395.6) | 20% |
  Diabetes mellitus | 2,207.8 (1461.1–3173) | 2,807.9 (1,906.5–4,022.5) | 27% | 3,490.7 (2,731.4–4,487.2) | 3,954.2 (3,014.9–5,187.7) | 13% |
  Acute glomerulonephritis | 0 (0–0.1) | 0 (0–0) | −9% | 3.8 (2.4–6.7) | 2.5 (1.1–3.9) | −34% |
  Chronic kidney diseases | 537.1 (370.6–805.8) | 770.3 (538.4–1101) | 43% | 1,371.7 (1,146.5–1,649.9) | 1,590.2 (1,313.1–1,967.6) | 16% |
  Chronic kidney disease due to diabetes mellitus | 80.8 (52.9–117.2) | 119.3 (78.1–172.1) | 48% | 214.8 (173.7–261.2) | 242 (190.6–308.7) | 13% |
  Chronic kidney disease due to hypertension | 99.2 (66.2–147.1) | 143.9 (97.4–204.3) | 45% | 264.7 (219.2–322.4) | 315.3 (257.2–393.6) | 19% |
  Chronic kidney disease unspecified | 357.1 (240.4–547.6) | 507.1 (352.2–735) | 42% | 892.2 (740.5–1101.4) | 1,032.9 (841.5–1,303.6) | 16% |
  Urinary diseases and male infertility | 395.5 (254.4–603.1) | 541.2 (347.1–812.7) | 37% | 604.2 (451.8–809.5) | 963.5 (717.5–1,265.4) | 59% |
  Tubulointerstitial nephritis, pyelonephritis, and urinary tract infections | 5.9 (2.6–11.2) | 7.4 (3.5–14.3) | 27% | 156.5 (124.4–229.1) | 328.8 (177.1–474.9) | 110% |
  Urolithiasis | 50 (27.3–81.3) | 72.6 (40.1–114.7) | 45% | 59.1 (36–91.8) | 78.8 (46.4–122.1) | 33% |
  Benign prostatic hyperplasia | 319.6 (201.5–487.1) | 431.8 (270.1–654.1) | 35% | 319.6 (201.5–487.1) | 431.8 (270.1–654.1) | 35% |
  Male infertility | 3.2 (1.2–7.1) | 4.2 (1.6–9) | 32% | 3.2 (1.2–7.1) | 4.2 (1.6–9) | 32% |
  Other urinary diseases | 16.9 (9.5–27.4) | 25.1 (14.1–40.3) | 49% | 65.9 (51.6–86) | 119.8 (87.9–155.5) | 82% |
  Gynecological diseases | 464.2 (258.8–797) | 585.2 (325.2–999) | 26% | 468.9 (263.7–801.4) | 590.4 (330–1,004) | 26% |
  Uterine fibroids | 96.8 (43.5–190.7) | 139.2 (60.2–268.9) | 44% | 97.2 (43.9–191.1) | 139.7 (60.8–269.4) | 44% |
  Polycystic ovarian syndrome | 142.4 (66.4–265.2) | 170.3 (77.9–324.2) | 20% | 142.4 (66.4–265.2) | 170.3 (77.9–324.2) | 20% |
  Female infertility | 2.5 (0.9–5.4) | 3.1 (1.1–6.7) | 24% | 2.5 (0.9–5.4) | 3.1 (1.1–6.7) | 24% |
  Endometriosis | 27.1 (9–52.7) | 34.3 (12.4–66.5) | 27% | 27.1 (9–52.7) | 34.3 (12.4–66.5) | 27% |
  Genital prolapse | 123.8 (49.5–259.5) | 156.3 (62.6–339.3) | 26% | 124.2 (49.9–259.9) | 156.7 (63–339.7) | 26% |
  Premenstrual syndrome | 71.7 (0–200.2) | 82.1 (0–213.6) | 14% | 71.7 (0–200.2) | 82.1 (0–213.6) | 14% |
  Other gynecological diseases | 0 (0–0) | 0 (0–0) | –* | 3.9 (3.4–4.6) | 4.2 (3.3–5.4) | 10% |
  Hemoglobinopathies and hemolytic anemia | 498.7 (296.2–1080.4) | 477.4 (291.8–935) | −4% | 599.4 (393.7–1,169.3) | 540.7 (350.5–997.4) | −10% |
  Thalassemia | 161.4 (102.1–247.1) | 156.1 (99.3–254.6) | −3% | 174.9 (115.5–260.7) | 162.3 (105.8–260.9) | −7% |
  Sickle cell disorders | 309.9 (171.6–832.4) | 296.2 (172.1–703.8) | −4% | 338.4 (199.5–859.6) | 309.3 (184.8–715.3) | −9% |
  G6PD deficiency | 24.8 (11.7–93.6) | 18.3 (9.3–58.9) | −26% | 32.5 (19–101.1) | 22.5 (13.2–62.6) | −31% |
  Other hemoglobinopathies and hemolytic anemia | 2.5 (0.5–1.8) | 6.7 (0.9–9.3) | 169% | 53.6 (36.2–64.7) | 46.6 (31.4–79.2) | −13% |
  Other endocrine, nutritional, blood, and immune disorders | 142.4 (83.1–228.4) | 199.8 (115.9–362) | 40% | 474.8 (329.2–710.6) | 773.4 (529.7–1,539.3) | 63% |
Musculoskeletal disorders | 11,220.4 (,8585.2–14,277.6) | 14,278.5 (10,905.8–17,775.5) | 27% | 11,469.4 (88,29.8–14,558.2) | 14,654.1 (11,291.8–18,160.2) | 28% |
  Rheumatoid arthritis | 477.5 (345.2–636.5) | 665.5 (465.5–881) | 39% | 519.4 (384.9–684.3) | 710.1 (509.5–925.6) | 37% |
  Osteoarthritis | 1,055.3 (648.4–1,604.3) | 1,407.1 (877.8–2,066.2) | 33% | 1,055.3 (648.4–1,604.3) | 1,407.1 (877.8–2,066.2) | 33% |
  Low back and neck pain | 7,363.4 (5,148.2–9,886.3) | 9,178.1 (6,357.5–12,295.1) | 25% | 7,363.4 (5,148.2–9,886.3) | 9,178.1 (6,357.5–1,2295.1) | 25% |
  Low back pain | 4,784.5 (3,305.8–6,484.6) | 6,011.7 (4,104.5–8,080.9) | 26% | 4,784.5 (3,305.8–6,484.6) | 6,011.7 (4,104.5–8,080.9) | 26% |
  Neck pain | 2,578.9 (1,769.5–3,608.8) | 3,166.3 (2,193.9–4,438) | 23% | 2,578.9 (1,769.5–3,608.8) | 3,166.3 (2,193.9–4,438) | 23% |
  Gout | 21.6 (13.4–32.1) | 30.2 (19–45.1) | 40% | 21.6 (13.4–32.1) | 30.2 (19–45.1) | 40% |
  Other musculoskeletal disorders | 2,302.7 (1,585.5–3,228.6) | 2,997.7 (2,089.4–4,136.6) | 30% | 2,509.7 (1,803.7–3,433.4) | 3,328.7 (2,440.8–4,471.4) | 33% |
Other non-communicable diseases | 4,700.2 (3,172.4–6,899.1) | 5,087.8 (3,400.3–7,616.6) | 8% | 6,009.2 (4,467.8–8,218.2) | 5,881.5 (4,184.3–8,375.2) | −2% |
  Congenital anomalies | 130.9 (93.7–182.5) | 141 (101.2–201.8) | 8% | 1,278.3 (1,065.6–1,416.6) | 778.7 (685.8–973.5) | −39% |
  Neural tube defects | 11.6 (6.4–18.7) | 8.2 (4.4–13.6) | −29% | 99.4 (58.5–126.5) | 18.5 (12.5–28) | −81% |
  Congenital heart anomalies | 34.2 (17.6–66.8) | 32.4 (15.9–67.4) | −5% | 566.6 (460.8–650.2) | 321.4 (254.9–411.9) | −43% |
  Cleft lip and cleft palate | 5.4 (2.7–9.7) | 6 (3.1–10.5) | 12% | 7.9 (4.9–12.4) | 7.4 (4.3–12.1) | −6% |
  Down’s syndrome | 38.1 (21.6–61.4) | 46.5 (27.1–74.6) | 22% | 104 (69.3–138.5) | 104.7 (80.1–136) | 1% |
  Other chromosomal abnormalities | 14.5 (8–23.9) | 17.4 (10.1–29.2) | 19% | 59.4 (41.1–78.5) | 55 (39.2–77.1) | −7% |
  Other congenital anomalies | 27.1 (19.1–38.3) | 30.6 (21.8–44.9) | 13% | 441 (294.4–539.7) | 271.6 (215.5–397.8) | −38% |
  Skin and subcutaneous diseases | 1,989.9 (1,235.6–3,086) | 2,206.8 (1,347–3,476.9) | 11% | 2,058.2 (1,302–3,150.8) | 2,301.8 (1,445–3,558.5) | 12% |
  Eczema | 462.2 (233.8–802) | 511.7 (252.5–845.6) | 11% | 462.2 (233.8–802) | 511.7 (252.5–845.6) | 11% |
  Psoriasis | 87.3 (42.4–145.8) | 105.1 (50–172.9) | 20% | 87.3 (42.4–145.8) | 105.1 (50–172.9) | 20% |
  Cellulitis | 11.1 (1.2–45.6) | 11 (1.3–45.3) | −1% | 26.2 (15.7–60.2) | 29.6 (16.9–63.8) | 13% |
  Abscess, impetigo, and other bacterial skin diseases | 41.8 (16.9–85.1) | 49.3 (19.8–101.3) | 18% | 63.3 (38–107.4) | 76 (45.7–129.6) | 20% |
  Scabies | 22.9 (10.1–44.9) | 26.2 (11.8–49) | 15% | 22.9 (10.1–44.9) | 26.2 (11.8–49) | 15% |
  Fungal skin diseases | 107.6 (33.8–246.6) | 128.2 (39.3–291.8) | 19% | 107.6 (33.8–246.6) | 128.2 (39.3–291.8) | 19% |
  Viral skin diseases | 189.2 (72.5–359.4) | 182.5 (66.3–336.4) | −4% | 189.2 (72.5–359.4) | 182.5 (66.3–336.4) | −4% |
  Acne vulgaris | 312.6 (139.6–589.8) | 237.6 (106.6–469.3) | −24% | 312.6 (139.6–589.8) | 237.6 (106.6–469.3) | −24% |
  Alopecia areata | 78.7 (23–158.4) | 91.1 (25.1–182.4) | 16% | 78.7 (23–158.4) | 91.1 (25.1–182.4) | 16% |
  Pruritus | 179.4 (82.5–347.4) | 244.2 (110.2–489.4) | 36% | 179.4 (82.5–347.4) | 244.2 (110.2–489.4) | 36% |
  Urticaria | 137.4 (55.3–236.9) | 159 (65–271) | 16% | 137.4 (55.3–236.9) | 159 (65–271) | 16% |
  Decubitus ulcer | 30 (9.8–69.2) | 40.3 (12.9–96.9) | 34% | 61.5 (39.8–101.6) | 89.7 (55–150.1) | 46% |
  Other skin and subcutaneous diseases | 329.6 (155.1–610.6) | 420.8 (193.8–806.2) | 28% | 329.8 (155.2–610.6) | 421 (193.9–806.3) | 28% |
Sense organ diseases | 1637 (1164–2335) | 1,850.2 (1291.1–2,656.9) | 13% | 1,637 (1,164–2,335) | 1,850.2 (1,291.1–2,656.9) | 13% |
  Glaucoma | 36 (23–54.9) | 56.9 (37.6–82.7) | 58% | 36 (23–54.9) | 56.9 (37.6–82.7) | 58% |
  Cataracts | 193.1 (136.8–261.7) | 170.7 (116.3–233.8) | −12% | 193.1 (136.8–261.7) | 170.7 (116.3–233.8) | −12% |
  Macular degeneration | 58.4 (37.5–87.3) | 107.8 (71.8–152.9) | 85% | 58.4 (37.5–87.3) | 107.8 (71.8–152.9) | 85% |
  Refraction and accommodation disorders | 84 (61.3–110.7) | 107.9 (77.6–142.3) | 28% | 84 (61.3–110.7) | 107.9 (77.6–142.3) | 28% |
  Other hearing loss | 926.8 (541.4–1480.3) | 962.7 (554.5–1598.5) | 4% | 926.8 (541.4–1,480.3) | 962.7 (554.5–1,598.5) | 4% |
  Other vision loss | 329.9 (174.9–586) | 433.2 (222–771) | 31% | 329.9 (174.9–586) | 433.2 (222–771) | 31% |
  Other sense organ diseases | 8.8 (3–19.8) | 11 (3.7–25.4) | 25% | 8.8 (3–19.8) | 11 (3.7–25.4) | 25% |
Oral disorders | 942.4 (564.3–1507.7) | 889.8 (519.4–1403.9) | −6% | 942.4 (564.3–1,507.7) | 889.8 (519.4–1,403.9) | −6% |
Dental caries | 110.2 (45–216.1) | 130.4 (52.8–250.1) | 18% | 110.2 (45–216.1) | 130.4 (52.8–250.1) | 18% |
Periodontal disease | 143 (54.8–312.3) | 193.8 (72.6–400.1) | 36% | 143 (54.8–312.3) | 193.8 (72.6–400.1) | 36% |
Edentulism | 689.2 (394.8–1103.5) | 565.6 (322–903) | −18% | 689.2 (394.8–1103.5) | 565.6 (322–903) | −18% |
Sudden infant death syndrome | 0 (0–0) | 0 (0–0) | –* | 93.3 (40.6–150.8) | 61 (31.4–111.4) | −35% |
Injuries | 3,873.3 (2,679.9–5,500.9) | 5,495 (3,846.6–7,727.1) | 42% | 11,961.1 (10,559.1–13,749.9) | 9,962.5 (8,154–12,170.7) | −17% |
Transport injuries | 1,134 (763.2–1,670.3) | 1,428.6 (975–2,074.9) | 26% | 4,925.5 (4,315.5–5,683.5) | 3,047.6 (2,494.2–3,809.3) | −38% |
  Road injury | 982.9 (659–1,450.2) | 1,197.1 (810.2–1,745.7) | 22% | 4,671.5 (4,049.7–5,342.3) | 2,692.9 (2,226.1–3,328.1) | −42% |
  Pedestrian injury by road vehicle | 169 (113.6–248.3) | 243.2 (165–350.8) | 44% | 580.3 (487.4–761.5) | 464.4 (372.3–584.4) | −20% |
  Pedal cycle vehicle | 18.8 (12.7–27.8) | 50.5 (34.2–74.1) | 169% | 71.2 (53.8–110.9) | 107.2 (75.3–136.5) | 51% |
  Motorized vehicle with two wheels | 232.4 (155.6–347.3) | 172.6 (116.1–252.7) | −26% | 1,423.3 (1,009.6–1,638.8) | 436 (360.3–539.5) | −69% |
  Motorized vehicle with three or more wheels | 576.6 (386.6–852.7) | 779.7 (527.3–1134.8) | 35% | 2,579.1 (2,156.9–3,157.2) | 1,722.1 (1,368.2–2,279.8) | −33% |
  Road injury other | 13 (8.8–19.2) | 12.1 (8.2–17.4) | −7% | 44.6 (31.7–60) | 24 (17.7–33.7) | −46% |
  Other transport injury | 151.1 (102.4–223) | 231.5 (157.9–331.2) | 53% | 254 (189.8–359.6) | 354.8 (275.4–460.4) | 40% |
Unintentional injuries other than transport injuries | 2,638 (1,821–3,727.8) | 3,944 (2,760.5–5,515.8) | 50% | 5,486.5 (4,503.8–6,659) | 5,472.7 (4,205.3–7,082.7) | 0% |
  Falls | 2,150.2 (1,471.2–3043.3) | 3,315.8 (2,316.6–4,644.3) | 54% | 2,462.8 (1,754.8–3,385.5) | 3,763.4 (2,726.7–5,125) | 53% |
  Drowning | 9.7 (6.1–14.5) | 11.1 (7–16.8) | 14% | 404.4 (312.7–497.3) | 222.8 (181–295.5) | −45% |
  Fire, heat and hot substances | 57 (30.5–106.3) | 70.2 (37.6–127.1) | 23% | 158.1 (122.4–213) | 141 (105.1–202.2) | −11% |
  Poisonings | 9.2 (5.6–14.6) | 7.1 (4.3–11.3) | −23% | 220.6 (153.6–338.5) | 165.9 (79.7–233.9) | −25% |
  Exposure to mechanical forces | 72.6 (45.5–114) | 75.2 (47.8–113.9) | 4% | 269.1 (212.6–366.4) | 185.4 (130.8–252.4) | −31% |
  Mechanical forces (firearm) | 26.9 (17–42.2) | 14.6 (9.4–22.2) | −46% | 94.8 (56.5–123) | 31.6 (22.7–47.7) | −67% |
  Mechanical forces (other) | 56.5 (35.4–88.2) | 79.1 (50.2–119.5) | 40% | 185.1 (147.6–282.1) | 172.3 (131.7–241.7) | −7% |
  Adverse effects of medical treatment | 45.3 (29.2–68.3) | 102.6 (66–151.3) | 127% | 143.5 (115.6–181.7) | 227.3 (174.5–307.9) | 58% |
  Animal contact | 21.9 (14.2–32.8) | 11.7 (7.7–17.2) | −47% | 35.3 (26.2–47.7) | 18.6 (14–25.1) | −47% |
  Animal contact (venomous) | 14.3 (8.7–22.3) | 6.8 (4.3–10.5) | −53% | 16.4 (10.6–24.8) | 8.3 (5.6–12.2) | −50% |
  Animal contact (non-venomous) | 7.6 (4.8–11.8) | 4.9 (3–7.3) | −36% | 18.9 (13.9–24.7) | 10.3 (7.8–13.9) | −45% |
  Unintentional injuries not classified elsewhere | 272.1 (185.1–396.4) | 350.3 (232.7–505.7) | 29% | 1,792.7 (1,054.8–2,031) | 748.2 (605.7–955.4) | −58% |
Self-harm and interpersonal violence | 101.3 (66.6–146.4) | 122.3 (81.1–173) | 21% | 1,549.1 (1,277.2–2,016.4) | 1,442.2 (1,051.7–1,690.9) | −7% |
  Self-harm | 12.6 (7.9–18.3) | 15.2 (9.7–23.1) | 21% | 1,244.6 (9,62.4–1,686.8) | 1,154.4 (7,59.7–1,377.5) | −7% |
  Interpersonal violence | 88.7 (58.4–129.4) | 107.1 (70.8–151.4) | 21% | 304.5 (241.9–403) | 287.8 (230.5–369.8) | −5% |
  Assault by firearm | 23.2 (15–34.3) | 30.1 (19.5–42.9) | 30% | 74.6 (59–105.3) | 74.2 (57.3–98.9) | −1% |
Assault by sharp object | 31.9 (20.9–46.9) | 56.2 (37–79.6) | 76% | 106.7 (79.1–175.7) | 143.2 (94.8–186.6) | 34% |
  Assault by other means | 40.1 (26.5–57.7) | 31.3 (21–43.8) | −22% | 129.7 (98.4–158.1) | 80.9 (65.5–106) | −38% |